Cian McCarthy Profile picture
Cardiology Fellow @MGHHeartHealth | Former Internal Medicine Resident @MGHMedicine | Alum: @UCC | Irish ☘️ | Sports fanatic

Dec 8, 2021, 6 tweets

Session 3 of #BacktoHeart21 happening now and covering #Lipids moderated by @FaRodriguezMD @PamelaBMorris & @DLBHATTMD!

First up @alanbrownmd covers COVID-19 and statin therapy! Promising observational data and many RCTs ongoing!

@MedscapeLIVE

@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE Next up @PamelaBMorris discusses lipid lowering beyond statins!

More data to come for bempedoic acid, Evinacumab, and Inclisiran! Lots of options emerging for LDL lowering

@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson provides a expert review of HIV and ischemic heart disease!

> HIV patients have high rates of CV events
> Lipid lowering therapy are underutilized
> 1/4 patients are treated with contraindicated statins or doses

@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson @JSaseenPharmD discussed TG lowering therapy and CV disease!

> EPA only omega 3 products beneficial with significant reduction in CV events demonstrated in the REDUCE-IT trial
> Be mindful of the increased risk of AF

@PamTaubMD discusses primary prevention for high-risk patients

> Dr. Taub makes a strong argument for incorporting more biomarkers beyond LDL to guide risk and management
> More personalized management needed to prevent events!

@DLBHATTMD provides a masterclass overview on antiplatelet and anticoagulant therapy for CVD to wrap up the session!

Dr. Bhatt discusses duration of DAPT & addition of low dose anticoagulation for stable CAD!

#BacktoHeart21

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling